Business Insights, PHARMACY MARKET
Visiox Pharma LLC | December 09, 2022
Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to address highly prevalent diseases in need of new treatment options, today announced that it has received notification from the U.S. Food and Drug Administration that the agency has completed its filing review and accepted for filing the New Drug Application for PDP-716 for the treatment of glaucoma.
The FDA has assigned a Prescription Drug User ...
Read More